Fabheads

Fabheads operates as a pioneer in automated composite manufacturing. The company specializes in carbon fiber 3D printing and end-to-end fabrication services for aerospace, automotive, marine and biomedical sectors. Its unique value proposition centers on "precision through automation"—leveraging patented Adaptive Toe Placement (ATP) technology to replace labor-intensive composite production with robotic accuracy, reducing costs by 50% and material waste by 20%.

Key milestones 

• $13M total funding: $1.07M Pre-Series A (2021) + $10M Series A (2025) led by Accel and Trifecta Capital.

• Defense innovation: Awarded iDEX project to develop carbon fiber helicopter blades for Indian Air Force (2021).

• Global recognition: National Startup Award (2020), DRDO’s Dare to Dream Award (2019).

Core Products & Services

• FibrBot Series: 3D printers (300S, 300, 1K) for continuous carbon fiber printing only indigenous solution.

• End-to-End Manufacturing: Design/FEA optimization, Prototyping to mass production and Hybrid fabrication (3D printing + traditional methods).

• Aerospace: Lightweight drone/rocket components.

• Medical: Carbon fiber implants (R&D phase).

• Automotive: EV parts with 30% weight reduction.

Business Model & Revenue Streams

1. Revenue Streams (2025)

• Manufacturing Services (60%): ₹30 crore from client projects (e.g., drone airframes for E-plane Company).

• Equipment Sales (30%): FibrBot printers ($50K–$150K/unit).

• Licensing/IP (10%): ATP technology royalties.

2. Geographic Mix

• Domestic (85%): Tamil Nadu (40%), Karnataka (30%), Maharashtra (15%).

• International (15%): Singapore, EU pilots.

Customer Segmentation

• B2B (100%): Aerospace/defense (50%), automotive (30%), biomedical (20%).

Top Clients & Partnerships

1. Industrial Leaders

• Synergy Marine: Shipbuilding composites.

• Tata Group: EV battery casings.

2. Tech Collaborations

• IIT Madras: R&D hub for material science.

• Accel: Scaling support for EU expansion.

Future Outlook & Strategic Priorities

• Aerospace Scale-Up: Bengaluru facility targeting ISRO, Airbus contracts (operational 2026).

• Medical Certification: FDA/CE approvals for implants by 2027.

• International Expansion: Germany/UK offices via EU partnerships.

• Product Innovation: 5-meter-part printers for railway sectors (e.g., Vande Bharat prototypes).

• Regulatory Hurdles: Medical device certification delays.

• Supply Chain Dependencies: Carbon fiber tariff volatility (60% imported).